Tenders of Aok Niedersachsen Die Gesundheitskasse

To the active ingredient Zolmitriptan (atc-code: N02cc03) Provides the Aok Lower Saxony. The health insurance for the period up to the entry into force of exclusive contracts In consequence of a formal award procedure In accordance with the regulations of the 4th part of the Gwb Allen Interested Pharmaceutical Companies, Without a selection decision, discount contracts An. The conclusion of the contract Successes In the context of a “open-house model” And Funging As a bridge between the beginning of the Generic competition (patent sequence) And the supplement of exclusion agreements. The offers contracts are not exclusive; Contracts With Allen market participants (pharmaceutical companies) Are pages The Aok Lower Saxony desired. In the open-house model Gelten For All participants Uniform conditions. Contract contents, conditions and access procedures are uniform – Individual negotiations are not carried out in principle. Contract term Amounts Maximum twenty-four months, The earliest start of the contract is The 01.06.2023. All contracts Ends Late Ends On 31.05.2025, Independent From the date of each contract conclusion. Joined Bzw. A conclusion can be achieved within the twenty-four-month period in each case for the first one month. There is a right to terminate each six weeks at the end of the month. The Aok Lower Saxony. The Health Insurance Treasury Behaves Pre, Already During the Contract term The Non-Exclusive Open-house Discount Contracts Replace by Exclusive Discount Contracts. With the entry into force Described, Exclusive Discount Contracts Become the Open-house Contracts According to The Contractual Regulation Finished, D. H. The Open-house Contract Ends Automatically. The Aok Lower Saxony Experiences Exclusive Discount Contracts As a rule Six to eight months After the publication The corresponding notice of invitation to tender In the Supplement to the Official Journal The European Union In force. The Future Contract Partners In the Open-house Model Become Prayer, Regarding This Notice of Call Regular In the Supplement to the Official Journal of the European Union To Inform. Interested pharmaceutical companies can request the contract documents as well as the contract terms under The I.1) Contracts To the active ingredient Zolmitriptan (atc-code: N02cc03) Become concluded for the first time with effect on 01.06.2023. Interested parties, The To This Date Contract Partners Want to, Have The Contract Documents to be submitted by 27.04.2023 At The Address mentioned in the Contract Documents. It Comes To Access At The Aok Lower Saxony. Later contract closures are During the twenty-four-month maximum duration ever. The Aok Necessary To The Required Works, e.g., The Contract Message In The Lauer-taxe® Ensure Skills. The exact periods of entry are announced with the contract documents. In the case of the above publication, Es sich Not Um The award of a public contract within the meaning of the Directive (2014/24/eu) Procurement law. In order to guarantee a farthest degree of transparency For the intended conclusion of the contract, the publication In the Supplement to the Official Journal of the European Union succeeds. In the absence of a corresponding publication form, the order notice is used. The term specifications resulting therefrom, such as e.g. The term “open procedure” is the only use of this publication form and the publication platform is due. A further meaning, In particular, a subjugation of subcontracting regulations, If you are not obligatory for legal reasons, Is that not related. The Procurement Is Related To A Project And/or Programme Financed By European Union Funds: No

Germany – Pharmaceutical Products – Abschluss Eines Nicht Exklusiven Rabattvertrages Nach § 130a Abs. 8 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Fusidinsäure (atc-code: D06ax01).

To the active ingredient Colecalciferol (atc-code: A11cc05) Provides the Aok Lower Saxony. The health insurance for the period up to the entry into force of exclusive contracts In consequence of a formal award procedure In accordance with the regulations of the 4th part of the Gwb Allen Interested Pharmaceutical Companies, Without a selection decision, discount contracts An. The conclusion of the contract Successes In the context of a “open-house model” And Funging As a bridge between the beginning of the Generic competition (patent sequence) And the supplement of exclusion agreements. The offers contracts are not exclusive; Contracts With Allen market participants (pharmaceutical companies) Are pages The Aok Lower Saxony desired. In the open-house model Gelten For All participants Uniform conditions. Contract contents, conditions and access procedures are uniform – Individual negotiations are not carried out in principle. Contract term Amounts Maximum twenty-four months, The earliest start of the contract is 01.04.2023. All contracts Ends Late Ends On 31.03.2025, Independent From the date of each contract conclusion. Joined Bzw. A conclusion can be achieved within the twenty-four-month period in each case for the first one month. There is a right to terminate each six weeks at the end of the month. The Aok Lower Saxony. The Health Insurance Treasury Behaves Pre, Already During the Contract term The Non-Exclusive Open-house Discount Contracts Replace by Exclusive Discount Contracts. With the entry into force Described, Exclusive Discount Contracts Become the Open-house Contracts According to The Contractual Regulation Finished, D. H. The Open-house Contract Ends Automatically. The Aok Lower Saxony Experiences Exclusive Discount Contracts As a rule Six to eight months After the publication The corresponding notice of invitation to tender In the Supplement to the Official Journal The European Union In force. The Future Contract Partners In the Open-house Model Become Prayer, Regarding This Notice of Call Regular In the Supplement to the Official Journal of the European Union To Inform. Interested pharmaceutical companies can request the contract documents as well as the contract terms under The I.1) Contracts To the active ingredient Colecalciferol (atc-code: A11cc05) Become concluded for the first time with effect on 01.04.2023. Interested parties, The To This Date Contract Partners Want to, Have The Contract Documents Towards 25.02.2023 To Submit Address Named In The Contract Documents. It Comes To Access At The Aok Lower Saxony. Later contract closures are During the twenty-four-month maximum duration ever. The Aok Necessary To The Required Works, e.g., The Contract Message In The Lauer-taxe® Ensure Skills. The exact periods of entry are announced with the contract documents. In the case of the above publication, Es sich Not Um The award of a public contract within the meaning of the Directive (2014/24/eu) Procurement law. In order to guarantee a farthest degree of transparency For the intended conclusion of the contract, the publication In the Supplement to the Official Journal of the European Union succeeds. In the absence of a corresponding publication form, the order notice is used. The term specifications resulting therefrom, such as e.g. The term “open procedure” is the only use of this publication form and the publication platform is due. A further meaning, In particular, a subjugation of subcontracting regulations, If you are not obligatory for legal reasons, Is that not related. The Procurement Is Related To A Project And/or Programme Financed By European Union Funds: No

Germany – Pharmaceutical Products – Abschluss Eines Nicht Exklusiven Rabattvertrages Nach § 130a Abs. 8 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Omalizumab (atc-code: R03dx05).

Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient tacrolimus (ATC code: L04AD02).

Germany-hanover: Immunosuppressive Agents

Germany – Pharmaceutical Products – Abschluss Eines Nicht Exklusiven Rabattvertrages Nach § 130a Abs. 8 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Lenograstim (atc-code: L03aa10).

Germany-hanover: Pharmaceutical Products

Germany – Pharmaceutical Products – Abschluss Eines Nicht Exklusiven Rabattvertrages Nach § 130a Abs. 8 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Glyceroltrinitrat (atc-code: C01da02).

Germany-hanover: Pharmaceutical Products